chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: feel like I have a cold; little itchy at the injection site; big pink area at the injection site; felt sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (feel like I have a cold), VACCINATION SITE PRURITUS (little itchy at the injection site), VACCINATION SITE ERYTHEMA (big pink area at the injection site) and VACCINATION SITE PAIN (felt sore at the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Nasal polyp. Concomitant products included DUPILUMAB (DUPIXENT) for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (little itchy at the injection site), VACCINATION SITE ERYTHEMA (big pink area at the injection site) and VACCINATION SITE PAIN (felt sore at the injection site). On 20-Jan-2021, the patient experienced NASOPHARYNGITIS (feel like I have a cold). At the time of the report, NASOPHARYNGITIS (feel like I have a cold) outcome was unknown and VACCINATION SITE PRURITUS (little itchy at the injection site), VACCINATION SITE ERYTHEMA (big pink area at the injection site) and VACCINATION SITE PAIN (felt sore at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient did not receive any treatment medications.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: injection site it was a little warm; pinkish spots at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (injection site it was a little warm) and VACCINATION SITE RASH (pinkish spots at injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE WARMTH (injection site it was a little warm) and VACCINATION SITE RASH (pinkish spots at injection site). At the time of the report, VACCINATION SITE WARMTH (injection site it was a little warm) and VACCINATION SITE RASH (pinkish spots at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: fever of 100.2°F; Arm hurting; woke up feeling really tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurting), FATIGUE (woke up feeling really tired) and PYREXIA (fever of 100.2°F) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm hurting) and FATIGUE (woke up feeling really tired). On an unknown date, the patient experienced PYREXIA (fever of 100.2°F). At the time of the report, PAIN IN EXTREMITY (Arm hurting), FATIGUE (woke up feeling really tired) and PYREXIA (fever of 100.2°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Body temperature: 100.2 f (Inconclusive) 100.2 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: bigger patch - at the injection site; Hardness at the injection site; Itching at the injection site - itching a lot; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (bigger patch - at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE (CLARITIN), MAGNESIUM and GUAIFENESIN for an unknown indication.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site). On 16-Jan-2021, the patient experienced VACCINATION SITE REACTION (bigger patch - at the injection site). The patient was treated with CORTISONE for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (bigger patch - at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site erythema, Vaccination site rash
Clinical narrative: Patch with size of fist coming and going at injection site; Rash at injection site; Redness at injection site; Itchy on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy on her left arm), RASH (Patch with size of fist coming and going at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an 112-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PRURITUS (Itchy on her left arm), RASH (Patch with size of fist coming and going at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, PRURITUS (Itchy on her left arm), RASH (Patch with size of fist coming and going at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medications.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Limb discomfort
Clinical narrative: heaviness in both legs; unstable feeling in both legs; This spontaneous case was reported by a patient and describes the occurrence of LIMB DISCOMFORT (heaviness in both legs) and FEELING ABNORMAL (unstable feeling in both legs) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Shoulder).    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (heaviness in both legs) and FEELING ABNORMAL (unstable feeling in both legs). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and IBUPROFEN at a dose of 800 mg. At the time of the report, LIMB DISCOMFORT (heaviness in both legs) and FEELING ABNORMAL (unstable feeling in both legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Vaccination site pain
Clinical narrative: Hot Feeling Radiating from Left Ear; Pain - Near the Injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot Feeling Radiating from Left Ear), VACCINATION SITE PAIN (Pain - Near the Injection site) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for COPD.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced FEELING HOT (Hot Feeling Radiating from Left Ear), VACCINATION SITE PAIN (Pain - Near the Injection site) and HEADACHE (Headache). At the time of the report, FEELING HOT (Hot Feeling Radiating from Left Ear), VACCINATION SITE PAIN (Pain - Near the Injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure before pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included Prenatal Multivitamins for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 20-Jun-2021. On 28-Jan-2021, the patient experienced MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant). On 28-Jan-2021, MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 29-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Also a very little itch; Few days later noted redness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm). At the time of the report, VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (little bit of cough) and COVID-19 (positive for covid) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced COUGH (little bit of cough) and COVID-19 (positive for covid). At the time of the report, COUGH (little bit of cough) and COVID-19 (positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: positive (Positive) patient  tested positive for COVID-19..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-Jun-2021, contains non-significant information. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021 and was forwarded to Moderna on 19-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (little bit of cough) and COVID-19 (positive for covid) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced COUGH (little bit of cough) and COVID-19 (positive for covid). At the time of the report, COUGH (little bit of cough) and COVID-19 (positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: positive (Positive) patient  tested positive for COVID-19..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up information received on 04-Jun-2021, contains non-significant information.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lump under lymph arm/Swollen lymph node (left); This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lump under lymph arm/Swollen lymph node (left)) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).  On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced LYMPHADENOPATHY (lump under lymph arm/Swollen lymph node (left)). The patient was treated with IBUPROFEN ongoing from 14-Jan-2021 at a dose of UNK UNK, qd. At the time of the report, LYMPHADENOPATHY (lump under lymph arm/Swollen lymph node (left)) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: NNI: Patient's email address updated.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: sore throat; fever; chills; headache; arm started to feel sore; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), Pain in extremity (arm started to feel sore), Oropharyngeal pain (sore throat), Pyrexia (fever) and Headache (headache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).  On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Jan-2021, the patient experienced CHILLS (chills), Pain in extremity (arm started to feel sore), Oropharyngeal pain (sore throat), Pyrexia (fever) and Headache (headache).   At the time of the report, CHILLS (chills), Pain in extremity (arm started to feel sore), Oropharyngeal pain (sore throat), Pyrexia (fever) and Headache (headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Injection site mass, Pyrexia
Clinical narrative: Lump on the arm; Loss of Taste; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Lump on the arm), AGEUSIA (Loss of Taste), CHILLS (Chills) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Blood pressure. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), VITAMIN D [VITAMIN D NOS] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced INJECTION SITE MASS (Lump on the arm), AGEUSIA (Loss of Taste), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 16-Jan-2021 at an unspecified dose and frequency.   At the time of the report, INJECTION SITE MASS (Lump on the arm), AGEUSIA (Loss of Taste), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a nurse and describes the occurrence of   in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is taking a Mab drug.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Rash
Clinical narrative: rash in the stomach; Chills; terrific pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (terrific pain), RASH (rash in the stomach) and CHILLS (Chills) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ISOSORBIDE and PANTOPRAZOLE for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (terrific pain) and CHILLS (Chills). On 18-Jan-2021, the patient experienced RASH (rash in the stomach). At the time of the report, PAIN (terrific pain) and CHILLS (Chills) had resolved and RASH (rash in the stomach) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: NNI
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching at inoculation site; Redness at inoculation site; Swelling at inoculation site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at inoculation site), VACCINATION SITE ERYTHEMA (Redness at inoculation site) and VACCINATION SITE SWELLING (Swelling at inoculation site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (non reported medical history).   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at inoculation site), VACCINATION SITE ERYTHEMA (Redness at inoculation site) and VACCINATION SITE SWELLING (Swelling at inoculation site).   At the time of the report, VACCINATION SITE PRURITUS (Itching at inoculation site), VACCINATION SITE ERYTHEMA (Redness at inoculation site) and VACCINATION SITE SWELLING (Swelling at inoculation site) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Appetite disorder, Asthenia, COVID-19, Chills, Dyspnoea
Clinical narrative: Swelling of the lymph nodes on both sides of my neck; Muscle aches; Difficult to breathe; Weakness; Sore throat; no longer hungry; Headache; Chills; Feverish; Pain at the injection site; Swelling of arm; Soreness of arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and OROPHARYNGEAL PAIN (Sore throat) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 30-Dec-2020, the patient experienced PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and INJECTION SITE PAIN (Pain at the injection site).   On 31-Dec-2020, the patient experienced DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle aches).   On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency.   At the time of the report, DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish), INJECTION SITE PAIN (Pain at the injection site), MYALGIA (Muscle aches) and LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Negative.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient was using hydrating and sleeping drugs for his symptoms.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Lymphadenopathy, Myalgia, Oropharyngeal pain
Clinical narrative: Swelling of the lymph nodes on both sides of my neck; Muscle aches; Difficult to breathe; Weakness; Sore throat; no longer hungry; Headache; Chills; Feverish; Pain at the injection site; Swelling of arm; Soreness of arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and OROPHARYNGEAL PAIN (Sore throat) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 30-Dec-2020, the patient experienced PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and INJECTION SITE PAIN (Pain at the injection site).   On 31-Dec-2020, the patient experienced DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle aches).   On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency.   At the time of the report, DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish), INJECTION SITE PAIN (Pain at the injection site), MYALGIA (Muscle aches) and LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Negative.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient was using hydrating and sleeping drugs for his symptoms.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Swelling of the lymph nodes on both sides of my neck; Muscle aches; Difficult to breathe; Weakness; Sore throat; no longer hungry; Headache; Chills; Feverish; Pain at the injection site; Swelling of arm; Soreness of arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and OROPHARYNGEAL PAIN (Sore throat) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 30-Dec-2020, the patient experienced PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm) and INJECTION SITE PAIN (Pain at the injection site).   On 31-Dec-2020, the patient experienced DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle aches).   On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency.   At the time of the report, DYSPNOEA (Difficult to breathe), ASTHENIA (Weakness), PERIPHERAL SWELLING (Swelling of arm), PAIN IN EXTREMITY (Soreness of arm), OROPHARYNGEAL PAIN (Sore throat), APPETITE DISORDER (no longer hungry), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Feverish), INJECTION SITE PAIN (Pain at the injection site), MYALGIA (Muscle aches) and LYMPHADENOPATHY (Swelling of the lymph nodes on both sides of my neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Negative.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient was using hydrating and sleeping drugs for his symptoms.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness
Clinical narrative: headache; Minor arm stiffness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Jan-2021, the patient experienced HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness).   At the time of the report, HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: positive covid test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive covid test) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced COVID-19 (positive covid test). At the time of the report, COVID-19 (positive covid test) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Very red inflated red spot here that doesn't seem to be going down; The spot is very hot, and very inflamed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Very red inflated red spot here that doesn't seem to be going down) and VACCINATION SITE WARMTH (The spot is very hot, and very inflamed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Very red inflated red spot here that doesn't seem to be going down) and VACCINATION SITE WARMTH (The spot is very hot, and very inflamed). At the time of the report, VACCINATION SITE ERYTHEMA (Very red inflated red spot here that doesn't seem to be going down) and VACCINATION SITE WARMTH (The spot is very hot, and very inflamed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: redness and a hard lump; redness and a hard lump; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and a hard lump) and VACCINATION SITE INDURATION (redness and a hard lump) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ROSUVASTATIN CALCIUM for Cholesterol, LISINOPRIL, CITALOPRAM, HYOSCYAMINE and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness and a hard lump) and VACCINATION SITE INDURATION (redness and a hard lump). At the time of the report, VACCINATION SITE ERYTHEMA (redness and a hard lump) and VACCINATION SITE INDURATION (redness and a hard lump) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medicine included cephalexin 500mg for 7 days and antihistaminic.   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Neck pain, Swelling
Clinical narrative: left side of neck swollen; neck feels hot; neck hurts to the touch; bad headache; A spontaneous case report sent by a other non-healthcare professional on 19-JAN-2021, concerning a 62-year-old Female who received Moderna's COVID-19 vaccince (mRNA-1273) experienced bad headache, neck swollen, neck feels hot and neck hurts when touched.  The patient medical history was not provided. No relevant concomitant medications was reported.  On 16-Jan-2021, the patient received first dose of Moderna's COVID-19 (mRNA-1273) (Lot number: 027L20A) Vaccine on left arm.  On 17-Jan-2021,the patient developed bad headache. On 19-Jan-2021, when patient woke up she experienced  left side of her neck swollen, neck feels hot, neck hurts when touched.  No treatment information was provided. The action taken for Moderna COVID-19 Vaccine (mRNA-1273) was unknown.  The outcome of the events for - bad headache  Unknow, neck hurts to the touch - Unknown, neck feels hot - Unknown, left side of neck swollen  Unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; Case reference number MOD-2021-009276 is a spontaneous case report sent by a Non-Health Professional on 19-JAN-2021 00:00:00 , which refers to a Male aged 72 Years .  The patients past medical history included: No adverse event   . .  On  the patient started taking Moderna COVID-19 Vaccine for . Some  later, the patient developed Chills. Over a period of the next <ENTER DURATION OF EVENT> days, the patient also developed . Relevant laboratory results included   and relevant physical signs were <LIST PHYSICAL SYMPTOMS>. The patient experienced the following serious criteria:. The eventual diagnosis made on was Chills . .  The patient was treated for the event with  . <ENTER ANY PROCEDURES> The action taken for Moderna COVID-19 Vaccine was  Unknown on . An autopsy was performed on .The Non-Health Professional did not declare any relatedness between chills and Moderna COVID-19 Vaccine In their opinion, other possible etiological factors included  <STATE OTHER FACTORS> and the patients age/ history or other factors <LIST OTHER RELEVANT  FACTORS> .  The company believes the following facts are also relevant in this case: <LIST OTHER RELEVANT FACTORS HERE> OR  <THERE IS NO KNOWN PLAUSIBLE MECHANISM BY WHICH THE DRUG WOULD CAUSE THE PRIMARY EVENT>.  The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons  (probably due to pre existing disease); there is no plausible mechanism to implicate the drug.  .   Terse Narrative (for narratives and signal review) Brief 3 line summary of above for CIOMS listing: Report Source- Non-Health Professional,  Age- 72 Years,  Sex- Male,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome-  .
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site warmth
Clinical narrative: Small sore area on arm; It's hot; Large red area on left arm; Fever of 99.9; red mark and a knot, golf ball size lump; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (red mark and a knot, golf ball size lump), VACCINATION SITE WARMTH (It's hot), VACCINATION SITE ERYTHEMA (Large red area on left arm), VACCINATION SITE PAIN (Small sore area on arm) and PYREXIA (Fever of 99.9) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included Spondylolisthesis on 05-Dec-2015 and Atrial fibrillation on 20-Oct-2011. Concurrent medical conditions included Alcohol allergy, Drug allergy (Allergic to Codiene), Seafood allergy (Allergic to TUNA cooked food), Irritable bowel syndrome since 03-May-2001, Blood pressure, Hypothyroidism and Back muscle spasms. Concomitant products included BISOPROLOL from 30-Oct-2011 to an unknown date for Atrial fibrillation, METHOCARBAMOL (ROBAXIN) from 12-Feb-2021 to an unknown date for Back muscle spasms, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) from 30-Oct-2011 to an unknown date for Blood pressure management, LEVOTHYROXINE SODIUM (SYNTHROID) from 09-Apr-1993 to an unknown date for Hypothyroidism, AMITRIPTYLINE from 10-Jan-2021 to an unknown date for Irritable bowel syndrome, PARACETAMOL (TYLENOL), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021 at 2:00 PM, the patient experienced VACCINATION SITE MASS (red mark and a knot, golf ball size lump), VACCINATION SITE ERYTHEMA (Large red area on left arm) and PYREXIA (Fever of 99.9). On 08-Jan-2021, the patient experienced VACCINATION SITE WARMTH (It's hot). On an unknown date, the patient experienced VACCINATION SITE PAIN (Small sore area on arm). On 28-Jan-2021, VACCINATION SITE MASS (red mark and a knot, golf ball size lump) and VACCINATION SITE ERYTHEMA (Large red area on left arm) had resolved with sequelae. At the time of the report, VACCINATION SITE WARMTH (It's hot), VACCINATION SITE PAIN (Small sore area on arm) and PYREXIA (Fever of 99.9) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The treatment information was not provided.   This case was linked to MOD-2021-207861 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Events and concomitant drugs added, information for events, reporter causality, action taken and medical history updated.
Sex: M
Vaccine: COVID19
Symptoms: Bedridden
Clinical narrative: kind of bed for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (kind of bed for 2 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (kind of bed for 2 days). At the time of the report, BEDRIDDEN (kind of bed for 2 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were provided by reporter.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Headache
Clinical narrative: Headache; Feeling Chilly; I feel tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I feel tired), HEADACHE (Headache) and FEELING COLD (Feeling Chilly) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L201A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (I feel tired), HEADACHE (Headache) and FEELING COLD (Feeling Chilly). At the time of the report, FATIGUE (I feel tired), HEADACHE (Headache) and FEELING COLD (Feeling Chilly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: swollen and heated rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (swollen and heated rash) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 18-Jan-2021, the patient experienced RASH (swollen and heated rash). At the time of the report, RASH (swollen and heated rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Benadryl. No concomitant medication were provided by reporter.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest discomfort, Chest pain, Cough
Clinical narrative: diarrhea; massive headache; weakness; shortness of breath; chest pain; chest pressure; cough; tested positive for Covid; hyposmia; postnasal drip; stiffness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia) and DIARRHOEA (diarrhea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2020, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and MUSCULOSKELETAL STIFFNESS (stiffness). On 30-Dec-2020, the patient experienced HYPOSMIA (hyposmia). On 31-Dec-2020, the patient experienced COVID-19 (tested positive for Covid), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and COUGH (cough). At the time of the report, COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain) and COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications include Sudafed, Tylenol, zinc , vitamin c, Z-pak and inhaler. No concomitant medications were provided by reporter.